179 related articles for article (PubMed ID: 38664879)
1. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
Han X; Zhang X; Liu Z; Fan H; Guo C; Wang H; Gu Y; Zhang T
J Diabetes; 2024 May; 16(5):e13564. PubMed ID: 38664879
[TBL] [Abstract][Full Text] [Related]
2. Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
Yu C; Wang L; Xue H; Lin H; Li Y; Chan SO
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):58-66. PubMed ID: 30274911
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.
Afolabi BI; Ibitoye BO; Ikem RT; Omisore AD; Idowu BM; Soyoye DO
J Natl Med Assoc; 2018 Jun; 110(3):256-264. PubMed ID: 29778128
[TBL] [Abstract][Full Text] [Related]
4. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
Jung CH; Lee B; Choi DH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Diabetes Res Clin Pract; 2017 Mar; 125():53-61. PubMed ID: 28167326
[TBL] [Abstract][Full Text] [Related]
5. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
[TBL] [Abstract][Full Text] [Related]
7. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.
Bilson J; Scorletti E; Bindels LB; Afolabi PR; Targher G; Calder PC; Sethi JK; Byrne CD
Nutr Diabetes; 2021 Oct; 11(1):32. PubMed ID: 34663793
[TBL] [Abstract][Full Text] [Related]
9. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
Xie Y; Kong W; Wang X; Wu Z
BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
[TBL] [Abstract][Full Text] [Related]
10. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
Ajmera V; Cepin S; Tesfai K; Hofflich H; Cadman K; Lopez S; Madamba E; Bettencourt R; Richards L; Behling C; Sirlin CB; Loomba R
J Hepatol; 2023 Mar; 78(3):471-478. PubMed ID: 36410554
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study.
Assarrar I; Messaoudi N; Ongoth FEM; Abdellaoui W; Malki A; Rouf S; Abda N; Ismaili Z; Latrech H
Rev Diabet Stud; 2022 Sep; 18(3):140-145. PubMed ID: 36309775
[No Abstract] [Full Text] [Related]
16. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
[TBL] [Abstract][Full Text] [Related]
17. Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients.
Wang Y; Yu Y; Wan H; Chen Y; Xia F; Zhang W; Zhang K; Gu X; Zhang Y; Lin Z; Yu Y; Wang N; Lu Y
Diabetes Metab Res Rev; 2020 Jul; 36(5):e3294. PubMed ID: 32017389
[TBL] [Abstract][Full Text] [Related]
18. The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects.
Yoo JH; Kang YM; Cho YK; Lee J; Jung CH; Park JY; Ryu OH; Kim HK; Lee WJ
Clin Endocrinol (Oxf); 2019 Aug; 91(2):271-277. PubMed ID: 31046138
[TBL] [Abstract][Full Text] [Related]
19. HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.
Chen C; Zhu Z; Mao Y; Xu Y; Du J; Tang X; Cao H
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31940026
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease.
Miyake T; Furukawa S; Matsuura B; Yoshida O; Miyazaki M; Shiomi A; Kanamoto A; Nakaguchi H; Nakamura Y; Imai Y; Koizumi M; Watanabe T; Yamamoto Y; Koizumi Y; Tokumoto Y; Hirooka M; Kumagi T; Takesita E; Ikeda Y; Abe M; Hiasa Y
Diabetes Metab J; 2024 May; 48(3):440-448. PubMed ID: 38310878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
